| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |